Welcome!
Moderna
Covid-19
Small is better for vaccine shares
Big vaccine news makes little difference to pharma giant shares.
November 25, 2020
Tong's Portfolio
Global economic recovery will be stronger than expected
Amid all the grim Covid-19 headlines, stock prices have continued to move higher.
November 20, 2020
Covid-19
Pfizer, BioNTech plan filing as vaccine proves 95% effective
A third contender, from AstraZeneca and the University of Oxford, is expected to release trial results in the coming days.
November 18, 2020
Covid-19
Moderna says Covid-19 vaccine is 94.5% effective in a preliminary analysis
A preliminary analysis of data from more than 30,000 volunteers showed Moderna’s vaccine prevented virtually all symptomatic cases
November 16, 2020
Global review
China could well be the winner of the Covid-19 vaccine race
The race is on for the first Covid-19 vaccine, with five Chinese companies among the 10 that are in phase III studies.
October 09, 2020
Covid-19
Is a viable Covid-19 vaccine imminent?
Dr Mike Ryan, head of WHO’s emergencies program maintains that there is still a long way to go before a vaccine can be rolled out.
July 22, 2020
Covid-19
Lonza in manufacturing deal with Moderna for Covid-19 vaccine
The parties plan to produce up to 1 billion doses of the vaccine per year
May 01, 2020